Acutus Medical Correlations
AFIBDelisted Stock | USD 0.73 0.03 3.95% |
The current 90-days correlation between Acutus Medical and Sientra is -0.28 (i.e., Very good diversification). The correlation of Acutus Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Acutus Medical Correlation With Market
Significant diversification
The correlation between Acutus Medical and DJI is 0.06 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Acutus Medical and DJI in the same portfolio, assuming nothing else is changed.
Acutus |
Moving together with Acutus Stock
Moving against Acutus Stock
0.5 | VREX | Varex Imaging Corp | PairCorr |
0.42 | FNA | Paragon 28 | PairCorr |
0.41 | PEN | Penumbra | PairCorr |
0.4 | MYO | Myomo Inc | PairCorr |
0.39 | VTAK | Catheter Precision | PairCorr |
0.37 | NXL | Nexalin Technology | PairCorr |
0.35 | OM | Outset Medical | PairCorr |
0.33 | ELMD | Electromed | PairCorr |
0.33 | XAIR | Beyond Air | PairCorr |
0.49 | GKOS | Glaukos Corp | PairCorr |
0.45 | GMED | Globus Medical | PairCorr |
0.42 | IART | Integra LifeSciences | PairCorr |
0.42 | ITGR | Integer Holdings Corp | PairCorr |
0.42 | LNSR | LENSAR Inc | PairCorr |
0.38 | MASI | Masimo | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Acutus Stock performing well and Acutus Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Acutus Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SSKN | 2.84 | (0.15) | 0.00 | (0.30) | 0.00 | 5.50 | 16.58 | |||
SIEN | 7.84 | 1.74 | 0.19 | 40.73 | 7.64 | 25.49 | 59.73 | |||
AXGN | 2.24 | 0.07 | 0.02 | 0.18 | 3.69 | 4.73 | 21.60 | |||
AIMD | 3.75 | (0.51) | 0.00 | (0.22) | 0.00 | 8.16 | 28.01 | |||
LNSR | 3.34 | 0.83 | 0.17 | 2.28 | 3.78 | 8.92 | 22.69 | |||
CVRX | 3.86 | 0.78 | 0.17 | 1.57 | 3.52 | 10.68 | 41.08 | |||
AXDX | 2.94 | (0.11) | 0.00 | 0.29 | 0.00 | 8.02 | 18.35 | |||
NPCE | 3.41 | 0.26 | 0.12 | 0.23 | 3.03 | 9.73 | 35.38 | |||
ANIK | 1.77 | (0.60) | 0.00 | (0.28) | 0.00 | 3.23 | 34.28 |
View Acutus Medical Related Equities
Risk & Return | Correlation |
Acutus Medical Corporate Management
Tom Sohn | Chief VP | Profile | |
Shibaji Shome | Vice Marketing | Profile | |
Charlie Piscitello | VP Officer | Profile | |
Vincent Burgess | Consultant | Profile | |
Gary Doherty | Senior Finance | Profile | |
David Roman | Pres CEO | Profile |
Still Interested in Acutus Medical?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.